Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics
- 1 June 2002
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 2 (6) , 400-407
- https://doi.org/10.1038/sj.tpj.6500138
Abstract
The CYP2D6 gene codes for human cytochrome P450 2D6 enzyme, which is responsible for the metabolism of many psychiatric drugs. In schizophrenic patients treated with neuroleptics, decreased or loss of function CYP2D6 alleles may contribute to the development of tardive dyskinesia (TD), a movement disorder that frequently occurs with chronic neuroleptic treatment. The goal of this study was to determine whether the occurrence of TD is associated with CYP2D6 genotype in a cohort of Korean schizophrenics by employing a CYP450 GeneChip((R)) oligonucleotide microarray and PCR assays to screen for 19 CYP2D6 alleles. Our results revealed that males with at least one decreased or loss of function allele have a moderately greater chance of developing TD than males with only wild-type alleles. Female schizophrenics did not have a significantly greater chance of developing TD. Our results demonstrate the utility of CYP2D6 microarrays to assess genotype status in this Korean cohort.Keywords
This publication has 33 references indexed in Scilit:
- CYP2D6 Genotyping with Oligonucleotide Microarrays and Nortriptyline Concentrations in Geriatric DepressionNeuropsychopharmacology, 2001
- Plasma concentrations of haloperidol are related toCYP2D6genotype at low, but not high doses of haloperidol in Korean schizophrenic patientsPublished by Wiley ,2001
- Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolutionPharmacogenetics, 1997
- MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG METABOLISMAnnual Review of Pharmacology and Toxicology, 1997
- Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotypeThe British Journal of Psychiatry, 1997
- Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean populationPharmacogenetics, 1996
- A new CYP2D6 allele with a nine base insertion in exon 9 in a Japanese population associated with poor metabolizer phenotypePharmacogenetics, 1996
- Polymorphic Drug Metabolism in Schizophrenic Patients With Tardive DyskinesiaJournal of Clinical Psychopharmacology, 1995
- Haloperidol Disposition Is Dependent on the Debrisoquine Hydroxylation PhenotypeTherapeutic Drug Monitoring, 1992
- Predictors of tardive dyskinesia: Results of a cross-sectional study in an outpatient populationJournal of Chronic Diseases, 1987